AngioDynamics (ANGO) Tops Q3 EPS by 4c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
AngioDynamics Reports Fiscal 2020 Third Quarter Financial Results
April 7, 2020 7:00 AM EDTFiscal 2020 Third Quarter Highlights
Net sales of $69.8 million increased 6.5% compared to the prior-year quarter Gross margin declined 40 basis points to 57.8% year over year GAAP loss per share of $0.15; adjusted earnings per share of $0.01 Launched PATHFINDER I Registry to evaluate performance and clinical outcomes of the AURYON Atherectomy System As a result of the uncertainty created by the COVID-19 pandemic, management is withdrawing its fiscal year 2020 financial guidanceLATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a... More
